Personal Finance
PFE

Why Pfizer Stock Gained 10% in July

^SPX Chart

What happened

Pfizer (NYSE: PFE) stock outpaced the market last month, gaining 10% compared to a 3.6% increase in the S&P 500 , according to data provided by S&P Global Market Intelligence .

The uptick pushed the drug giant's shares ahead of the market so far in 2018, with its 12% gain equating to about double the S&P 500's increase.

^SPX data by YCharts .

So what

Investors pushed Pfizer's stock higher late in the month in response to the company's second-quarter earnings report. That announcement showed a modest sales uptick despite the loss of patent protection for its blockbuster Viagra drug. Newer products like Prevnar and Eliquis filled that sales void and a lower tax liability allowed adjusted earnings to rise by 19%.

Many different types of pills on a blue background

Image source: Getty Images.

Now what

Pfizer reduced several of its short-term financial targets in late July, but only to account for unfavorable foreign currency moves. Over the long term, executives are bullish about its pipeline of as many as 15 potential blockbuster drugs that could be approved for commercial use between now and 2022. CEO Ian Read called that portfolio "the largest and most promising array of late-stage prospects" that Pfizer has had in decades, and investors incorporated that optimism into a rising stock price last month.

10 stocks we like better than Pfizer

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Pfizer wasn't one of them! That's right -- they think these 10 stocks are even better buys.

Click here to learn about these picks!

*Stock Advisor returns as of June 4, 2018

Demitrios Kalogeropoulos has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

PFE

Other Topics

Stocks

Latest Personal Finance Videos

    #TradeTalks: A Holistic Financial Picture to Give a True Indicator of your Financial Health

    Harvest Founder Nami Baral joins Jill Malandrino on Nasdaq #TradeTalks to discuss the Harvest PRO Index, holistic financial picture to give a true indicator of your financial health, not just a credit score.

    Oct 9, 2020

    The Motley Fool

    Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

    Learn More